Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic Leukemia
Clinical trial NCT02316197 · COMPLETED
Trial details
- NCT number
- NCT02316197
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-31
- Primary completion
- 2017-06-29
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.